Peter Seideman
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
Papers in
- Rheumatology 20
- Rheumatoid Arthritis Research and Therapies 17
- Pharmacology 13
- Pharmacogenetics and Drug Metabolism 13
- Inflammatory mediators and NSAID effects 7
- Co-authors
- Olof Beck (7 shared papers)Christer von Bahr (9 shared papers)Gunnar Alván (3 shared papers)Staffan Eksborg (5 shared papers)Roland Müller-Suur (2 shared papers)Freidoun Albertioni (5 shared papers)Curt O. Peterson (4 shared papers)Berit Calissendorff (2 shared papers)
In The Last Decade
Peter Seideman
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Rheumatology 315
- Pharmacology 219
- Ophthalmology 96
- Geriatrics and Gerontology 28
- Toxicology 41
Countries citing papers authored by Peter Seideman
This map shows the geographic impact of Peter Seideman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Seideman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Seideman more than expected).
Fields of papers citing papers by Peter Seideman
This network shows the impact of papers produced by Peter Seideman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Seideman. The network helps show where Peter Seideman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Seideman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 117 | |
| 2 | 1993 | 107 | |
| 3 | 1982 | 80 | |
| 4 | Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets. | 2004 | 69 |
| 5 | 1993 | 52 | |
| 6 | Psoriatic arthritis treated with oral colchicine. | 1987 | 50 |
| 7 | 1995 | 47 | |
| 8 | Renal effects of low dose methotrexate in rheumatoid arthritis. | 1993 | 44 |
| 9 | 1991 | 39 | |
| 10 | 1993 | 39 | |
| 11 | 1994 | 39 | |
| 12 | 1995 | 38 | |
| 13 | 1988 | 36 | |
| 14 | 1993 | 33 | |
| 15 | 1993 | 32 | |
| 16 | 1984 | 31 | |
| 17 | 1993 | 29 | |
| 18 | 1991 | 28 | |
| 19 | 1980 | 27 | |
| 20 | 1981 | 27 |
About Peter Seideman
Peter Seideman is a scholar working on Rheumatology, Pharmacology, Pharmacology, Cardiology and Cardiovascular Medicine and Ophthalmology, having authored 51 papers that have together received 1.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (17 papers), Pharmacogenetics and Drug Metabolism (13 papers), Blood Pressure and Hypertension Studies (9 papers), Inflammatory mediators and NSAID effects (7 papers), Acute Kidney Injury Research (2 papers), Glaucoma and retinal disorders (2 papers), Drug-Induced Ocular Toxicity (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Rheumatology (315 citations), Pharmacology (219 citations), Ophthalmology (96 citations), Geriatrics and Gerontology (28 citations) and Toxicology (41 citations). Peter Seideman has collaborated with scholars based in Sweden, Australia and Austria. Frequent co-authors include Olof Beck, Christer von Bahr, Gunnar Alván, Staffan Eksborg, Roland Müller-Suur, Freidoun Albertioni, Curt O. Peterson, Berit Calissendorff, Kjell Haglund and Gunnar Widmark. Their work appears in journals such as British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Lara D. Veeken and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.